EvoNexus Graduate Biolinq Achieves FDA De Novo Classification for Needle-Free, Autonomous Wearable Biosensor
EvoNexus portfolio company graduate Biolinq was granted FDA De Novo classification by the FDA for their Shine™ device, establishing a new device category for autonomous wearable biosensors. Their dermal microneedle […]